Significant Drug Interaction Between Fluvoxamine and Quetiapine (Seroquel)
Yes, there is a clinically significant pharmacokinetic interaction between fluvoxamine and quetiapine that requires dose adjustment of quetiapine when used together. Fluvoxamine substantially increases quetiapine blood levels, potentially leading to excessive sedation, hypotension, and other adverse effects.
Mechanism of Interaction
Fluvoxamine is a potent inhibitor of multiple CYP450 enzymes, particularly CYP1A2, CYP2C19, CYP2C9, CYP3A4, and CYP2D6 1. Quetiapine is primarily metabolized by CYP3A4 2. When fluvoxamine inhibits CYP3A4, quetiapine clearance is significantly reduced, leading to markedly elevated plasma concentrations.
Research data demonstrates a 159% increase in quetiapine serum concentrations when co-administered with fluvoxamine 3. This is one of the most pronounced drug interactions observed with quetiapine in clinical practice.
Clinical Management
Dose Adjustment Required
If quetiapine must be used with fluvoxamine, reduce the quetiapine dose to approximately one-sixth (1/6) of the original dose 2. This is the same magnitude of dose reduction recommended when quetiapine is combined with other potent CYP3A4 inhibitors like ketoconazole.
Monitoring Strategy
Start with the reduced quetiapine dose immediately when adding fluvoxamine to existing quetiapine therapy
Monitor closely for:
- Excessive sedation and drowsiness
- Orthostatic hypotension and dizziness 4
- Cognitive impairment
- Extrapyramidal symptoms (though less likely with quetiapine)
Monitor within the first 24-48 hours after initiating combination therapy, as this is when interaction effects become most apparent 1
Additional Considerations
Serotonin syndrome risk: While both drugs affect serotonergic systems, quetiapine is not primarily serotonergic. However, caution is warranted when combining fluvoxamine (an SSRI) with any psychotropic medication 1. Monitor for mental status changes, neuromuscular hyperactivity (tremors, hyperreflexia), and autonomic instability (tachycardia, hypertension, diaphoresis).
Anticholinergic effects: Both medications can have anticholinergic properties. The combination increases risk for severe gastrointestinal hypomotility and constipation 2.
QTc prolongation: Both fluvoxamine (particularly citalopram among SSRIs) and quetiapine can prolong the QT interval 1. Consider baseline and follow-up ECG monitoring, especially in patients with cardiac risk factors.
Alternative Strategies
If this combination is being considered for treatment-resistant depression or anxiety:
Consider alternative SSRIs with less CYP3A4 inhibition: Citalopram or escitalopram have the least effect on CYP450 enzymes compared to other SSRIs and may be safer options with quetiapine 1
Consider alternative antipsychotics: If an atypical antipsychotic augmentation is needed with fluvoxamine, options metabolized through different pathways may be preferable
Therapeutic drug monitoring: Given the substantial interaction, measuring quetiapine plasma levels can help guide dosing adjustments 3
Common Pitfalls to Avoid
- Do not assume standard quetiapine dosing is safe when fluvoxamine is present—the interaction is substantial and predictable
- Do not overlook this interaction in elderly patients who are already at higher risk for quetiapine-related adverse effects (67% higher baseline levels in patients ≥70 years) 3
- Do not discontinue fluvoxamine abruptly if the combination has been stable, as this will cause quetiapine levels to drop precipitously, potentially causing symptom relapse
- Remember that fluvoxamine has greater potential for drug-drug interactions than other SSRIs due to its broad CYP450 inhibition profile 1